Roux-en-Y gastric bypass attenuates the progression of cardiometabolic complications in obese diabetic rats via alteration in gastrointestinal hormones

RYGB has beneficial cardiometabolic effects through alterations in GI hormones in a severely obese and diabetic rodent model.